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Graphical Abstract 
 
 
Highlights- 
 A physiologically friendly polycaprolactone foaming procedure 
 Use of dense CO2 as foaming agent for creation of porous three-dimensional 
structures of polycaprolactone without supercritical conditions 
 A one step approach for foaming and loading of polycaprolactone with 
bioactive agents such as ß-tricalcium phosphate and dexamethasone  
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Abstract 
The preparation of three-dimensional polycaprolactone scaffolds using dense CO2 as foaming 
agent, without supercritical conditions, was evaluated in this study towards future applications 
in bone repair. Herein, 3D foams were obtained at 5.0 MPa and 45 °C. To induce bioactivity, β-
tricalcium phosphate (β-TCP, 10 wt%) and dexamethasone (5 and 10 wt%) were dispersed in the 
scaffolds. Foams revealed a pore size range of 164-882 m, 73-99% porosity and 79-99% 
interconnectivity, assessed by micro-computed tomography, and a Young modulus of 1.76-2.92 
MPa. Dexamethasone did not impair morphology of the matrices in comparison with PCL+β-
TCP, which presented a water uptake of nearly 100% after 14 days. A sustained release of 
dexamethasone was achieved over 35 days in physiologic solution. This study reports the 
feasibility of using dense CO2 to produce in one-step a porous matrix loaded with active agents 
opening new possibilities towards injectable systems for in situ foaming. 
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1. Introduction 
The development of 3D architectures for tissue engineering has challenged many researchers 
involved in different fields of knowledge. The ability to create a three-dimensional scaffold, 
which meets the morphological, mechanical, chemical and biological requirements for good 
cellular performance and tissue integration, is not straightforward. In this sense, the pursue for 
different processing techniques which can offer the most appropriate construct for the 
application of such purpose has been the goal of many different works reported in the literature. 
One of the techniques that has been extensively studied for polymer processing is the use of gas 
and/or supercritical foaming. This technique was firstly proposed by Mooney and co-workers 
back in 1996 [1] to produce a highly porous and interconnected structure for tissue engineering 
and regenerative medicine. In the work reported, foaming of poly(-lactic-co-glycolic acid) 
without the use of organic solvents was described. The thermodynamic principle underlying the 
gas foaming is the plasticization effect of the gas on the polymeric matrix, decreasing its glass 
transition and/or melting temperature. Upon decompression cells start to nucleate and the 
pores are formed [2–6]. Carbon dioxide is the supercritical fluid used per excellence, particularly 
due to its low critical properties (Pc= 7.4 MPa and Tc= 31 °C), but also due to its innocuity. The 
main constraint of the gas/supercritical foaming technique is, however, the limited ability of 
carbon dioxide to decrease the glass transition temperature of crystalline polymers, hence this 
processing can only be applied to amorphous or semi-crystalline polymers and the extent of 
foaming will be directly related to the affinity of carbon dioxide to the polymer.  
Since the pioneering work of Mooney, different polymers were tested. Particularly interesting 
for biomedical applications are different derivatives of polyesters such as poly(L-lactic acid) 
[7,8], poly(DL-lactic acid) [9,10], poly(lactic-co-glycolic acid) with different ratios of lactic and 
glycolic [9,11] and polycaprolactone (PCL). In this work we selected polycaprolactone, a FDA-
approved polymer used for several biomedical applications, which has attracted attention in 
bone tissue engineering for its biocompatibility, bioabsorbability and mechanical properties 
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[12]. Particularly in spinal fusion, PCL has demonstrated to yield successful bone fusion and 
maturation of newly formed bone, in large animal models such as pig [13,14] and sheep [15,16], 
outperforming bone graft [17,18].  
Several techniques are used to process PCL and PCL composites towards achieving optimal 
performing physicochemical properties for bone applications, such techniques including 
particulate leaching [19], compressive moulding [20], melt spinning [21], wet spinning [22], 
electrospinning [23], or fused deposition modeling (FDM) [13] / 3D-printing [24] , which yield a 
pre-fabricated scaffold suitable for implantation. The use of gas and/or supercritical foaming 
technique and experimental conditions proposed herein, brings the possibility of foam injection, 
for in situ formation of the 3D porous scaffold. The settled material shall achieve the specific 
format and dimensions of the osseous defect. Multiple manuscripts have reported different 
experimental conditions for gas and/or supercritical foaming of PCL, including polymers of 
several molecular weights and the presence of additives, as detailed in Table 1. 
Most of the work refers to supercritical fluid foaming, i.e. conditions in which carbon dioxide 
was used above its critical parameters of pressure and temperature. There are however two 
exceptions. Cotugno et al [26] report the foaming of polycaprolactone, in a two-step approach. 
The polymer is initially molten at temperatures higher than its melting temperature and 
pressurized with CO2. Afterwards the system is cooled and, upon depressurization of the system 
to ambient pressure, the foaming takes place. In this work [26] it is however difficult to assess 
which experiments are carried out at sub or supercritical conditions as the final pressure, before 
depressurization is not mentioned. Another work reported in the literature, by Di Maio and co-
workers [40] presents several experiments were carried out to foam polycaprolactone in a 
temperature range from 28-45 °C and a pressure range from 2.8-5.5 MPa. Although the 
manuscript presented does not provide extensive morphological characterization of the foams 
generated, it is possible to conclude that the foams prepared have small pore size diameter in 
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the range of 20-80 μm and a density between 0.05 and 0.25 g/cm3. The different approaches 
followed by Di Maio et al [40] aims the understanding of the effect of the operating conditions 
on the morphology of the scaffolds, but also the thermodynamics underlying the process. A 
more applied research has been reported by Annabi [37] and De Matos [41] which relates 
specifically to the preparation PCL based 3D architectures for tissue engineering and 
regenerative medicine. 
In 2003 David Tomasko and co-workers [43] have highlighted the main constrains of using 
carbon dioxide as foaming agent claiming that “The challenges of CO2 as a foaming agent are 
associated with the higher pressure operation, dimensional instability during the foam-shaping 
process (…)” [43]. 15 years later, the industry is still reluctant when it comes to high-pressure 
and supercritical technology. Despite the significant advances at the scale-up and translation 
from lab to bench scale the perception that working under high pressures and the requirement 
of sophisticated and expensive equipment, continues to hinder the use of supercritical fluid 
technologies at a larger scale. 
In this work, we evaluated the possibility to prepare 3D scaffolds from polycaprolactone under 
subcritical carbon dioxide atmosphere. The possibility to use milder processing conditions may 
open new strategies in bone regeneration, particularly through the development of a portable 
surgical tool for in situ foaming and foam delivery. 
 
2. Materials and methods 
2.1. Materials 
Poly-ε-caprolactone (PCL) (Mn 45000 Da and 80000 Da) in granular form was obtained from 
Sigma Aldrich and milled to powder using an ultra-centrifugal mill (Retsch ZM200) under liquid 
nitrogen. β-tricalcium phosphate (β-TCP) (CAS 7758-87-4) and dexamethasone (dex) (CAS50-02-
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2) were also obtained from Sigma Aldrich. Carbon dioxide (99.998 mol %) was supplied by Air 
liquid. All reagents were used as received without further purification. 
2.2. Subcritical carbon dioxide foaming 
The scaffolds were prepared by subcritical carbon dioxide foaming at 5.0 MPa and 45 °C. In each 
experiment c.a. 500 mg of PCL was loaded in a stainless steel cylindrical mold with 2 cm inner 
diameter and 1 cm height, which was placed inside the high-pressure vessel (2.5 cm inner 
diameter, 40 cm height) (Figure 1). The vessel was heated by means of an electric thin band 
heater (OGDEN) connected to a temperature controller, which maintained the temperature 
within ± 1 °C. The system was pressurized with carbon dioxide until the operational pressure 
was attained inside the vessel, measured with a pressure transducer. The system was closed for 
two hours to allow the plasticization of the polymer. Afterwards the system was slowly 
depressurized (depressurization rate ~0.15 MPa/min).  
When β-TCP and dexamethasone were loaded in the 3D construct, they were previously 
physically mixed with the PCL polymer and afterwards loaded in the mold. The foaming 
procedure was the same as described above. 
Figure 1. 
A summary of the samples prepared is listed in Table 2: 
2.3. Characterization of the 3D structures 
2.3.1. Scanning electron microscopy (SEM) 
Porous matrices obtained from the different formulations were observed by a Leica Cambridge 
S360 Scanning Electron Microscope (SEM). Cross sections of the specimens were examined after 
fracturing in liquid nitrogen. The matrices were fixed by mutual conductive adhesive tape on 
aluminum stubs and covered with gold palladium using a sputter coater. 
2.3.2. Micro-computed tomography (micro-CT) 
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The morphological structure and the calculation of the morphometric parameters that 
characterize the samples were evaluated by micro-computed tomography (micro-CT) using a 
Skyscan 1272 equipment (Bruker, Germany) with penetrative X-rays of 50 KeV and 200 µA, in 
high-resolution mode with a pixel size of 21.6 µm. A CT analyzer (v1.15.4.0, 2012-2015, Bruker 
Micro-CT) was used to calculate the parameters from the 2D images of the matrices. 
2.3.3. Compressive mechanical analysis 
Compressive mechanical analysis of the materials produced were measured using an INSTRON 
5540 (Instron Int. Ltd, High Wycombe, UK) universal testing machine with a load cell of 1 kN.  
The scaffolds were cut in cylindrical shape with 5 mm diameter and 4 mm height. Compression 
testing was carried out at a crosshead speed of 2 mm.min-1, until a maximum reduction in 
sample weight of 60 %. The compressive modulus is defined as the initial linear modulus on the 
stress/strain curves. The data presented is the result of the average of at least five 
measurements.  
2.4. Water uptake and degradation studies 
The water uptake ability of the matrices prepared was assessed for a period up to 14 days. 
Scaffolds of PCL and PCL + β-TCP prepared by dense gas foaming were weighed and immersed 
in 5 mL of an isotonic solution (Phosphate Buffered Saline, PBS) at pH = 7.4. The samples were 
placed in a water bath at 37 °C. After predetermined periods of time (1, 3, 7 and 14 days) the 
samples were weighed in order to determine the water uptake of the scaffolds. 
Water uptake was determined using the following equation (1): 
 (1) 
where ww is the weight of the wet sample and wi is the weight of the initial sample. 
The pH of each solution was also measured in order to determine the effect of polymer 
degradation on the acidity of the medium. 
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After immersion for 28 days the samples were dried at room temperature and weighed to 
determine the weight loss, which was calculated according to equation (2): 
(2) 
where wf is the final weight of the dry sample after immersion and wi is the initial weight of the 
sample. 
2.5. Drug release studies 
In vitro release studies of dexamethasone from PCL foams were performed by incubating the 
drug-loaded matrices in 20 mL of PBS, at pH 7.4 under horizontal shaking at 37 °C [23,44]. The 
release was performed in sink conditions. At appropriate time intervals (5 min, 30 min, 1 h, 1.5 
h, 2 h, 3 h, 4 h, 6 h, 24 h, 72 h, 7 days, 14 days, 21 days, 34 days), aliquots of 300 μL were 
withdrawn, and fresh volume of PBS was added to the suspension to replace the sample. The 
samples were quantified by UV-spectroscopy on a multi-well microplate reader (Synergy HT, 
Bio-Tek Instruments), using a quartz 96 well-plate. The optical density of dexamethasone was 
read at 245 nm. The results were presented as an average of three measurements.  
2.6. Cytotoxicity studies 
An immortalized mouse lung fibroblasts cell line (L929), from European Collection of Cell 
Cultures, UK, was maintained in basal culture medium DMEM (Dulbecco’s modified Eagle’s 
medium; Sigma–Aldrich, Germany), supplemented with 10% FBS (heat-inactivated fetal bovine 
serum, Biochrom AG, Germany) and 1% A/B (antibiotic–antimycotic solution, Gibco, UK). 
Confluent L929 cells were harvested, seeded in a 96 well plate at 1 x 103 cells/well using 
supplemented DMEM medium, and cultured for 24h. The indirect contact was performed by 
replacing the culture medium with leachables of the materials. The leachables were obtained 
after 24 hours of extraction using a ratio 100 mg of material in 1 mL supplemented DMEM. The 
samples were cultured for 48 hours under a 5% CO2 atmosphere at 37 °C, after which cell 
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metabolic activity was determined by the MTS assay (Cell Titer 96 Aqueous One Solution Cell 
Proliferation Assay (Promega, USA). Absorbance was measured at 490 nm using a microplate 
reader (Synergie HT, Bio-Tek, USA). Optical density was determined for sample and compared 
to polystyrene tissue culture plate, used as a negative control and latex extract used as a positive 
control. All cytotoxicity screening tests were performed using three replicates. 
 
3. Results and Discussion 
In this work, we have evaluated the possibility to foam polycaprolactone under subcritical 
carbon dioxide atmosphere. Literature review (Table 1) suggests that successful foaming of this 
polymer requires conditions above the critical parameters of carbon dioxide and little has been 
reported in what concerns the use of carbon dioxide at lower P, T conditions. The first variable 
optimized was the molecular weight of polycaprolactone as gas foaming is highly dependent on 
the molecular weight of the polymers. In this work, we tested different polycaprolactone 
polymers, with molecular weights of 45 000 and 80 000 Da. The experiments carried out have 
shown that under the processing conditions aimed in this study, i.e., below 5.0 MPa and 50 °C, 
polycaprolactone with a molecular weight of 80 000 Da did not foam. According to literature 
(Table 1), much higher conditions are required to achieve foaming of PCL 80 000 Da, i.e: pressure 
up to 20.0 MPa and/or temperatures above the melting temperature of the polymer. On the 
other hand, PCL 45 000 Da processed under 5.0 MPa and 50 °C could be foamed and was, for 
this reason, selected to proceed the optimization process. Two different pressures (4.0 and 5.0 
MPa) and different temperatures (between 37 to 50 °C) were tested, in order to further optimize 
the gas foaming process and determine the best operating conditions to prepare a 3D 
architecture able to meet the requirements set for bone tissue engineering. These experiments 
were performed with an exposure time of 2 hours. Figure 2 highlights the different set of 
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operating conditions reported in the literature for the foaming of PCL and the ones tested in this 
work.  
Figure 2. 
At 4.0 MPa and 45 °C, sintering of the particles takes place. Sintering under dense carbon dioxide 
atmosphere has been reported in the literature and relies on a minor plasticization effect of 
carbon dioxide [45]. In the experiments performed the polymer particles are fused, but a very 
fragile structure is obtained. The structure cannot be handled without compromising its 
integrity. On the other hand, increasing pressure to 5.0 MPa and 37 °C, a homogeneous and 
robust architecture is obtained, however we can consider that under these conditions still 
sintering and not foaming occurred. It is only when temperature is increased to 45 °C, with a 
carbon dioxide pressure of 5.0 MPa that foaming takes place. From the same amount of starting 
material, the sample prepared at 5.0 MPa and 45 °C has expanded much more than the sample 
prepared at 37 °C, presenting a larger volume and hence, lower density. From these results, we 
concluded that the best operating conditions were 45 °C and 5.0 MPa and these were therefore 
used for further processing of the constructs.  
The optimization of the required contact time for plasticization is another parameter which is 
crucial for the success of the polymer foaming. The plasticization of polycaprolactone was 
assessed using a high-pressure visual cell with a sapphire window. Imaging of the process was 
performed through sequential images which were captured in time lapse mode by computer 
software controlled program equipped with a Logitech (HD1080P) camera. Figure 3 shows 
selected images of the foaming process as a function of time. 
Figure 3. 
The images demonstrate that upon pressurization of the high-pressure cell, the polymer starts 
to plasticize after 10 minutes and after 30 minutes it is completely in the molten state. In the 
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decompression cycle, it is observed that the foaming occurs in the late stage of decompression 
of the vessel, when pressure is below 1.0 MPa. These observations are particularly relevant to 
optimize processing time. Fanovich and co-workers reported visual observations of the gas 
foaming for the system with polycaprolactone [39] and evaluated the temperature effect at 35 
and 40 °C and pressure of 15.0 up to 20.0 MPa. Under these conditions the PCL scaffolds are 
molten after 30 minutes in contact with the supercritical fluid. No major differences are 
observed in terms of the time requested for polymer plasticization/melting either in sub or 
supercritical conditions. This is particularly true when large differences in CO2 density are 
compared. For instance, in our work, the CO2 density of the gas phase is ~0.104 g/cm3 
(determined using a web computation tool provided by Penn State – Earth and Mineral Sciences 
Energy Institute), while in the work by Fanovich, CO2 density used was 0.839 g/cm3 in the 
experiments carried out in supercritical conditions (35 °C and 15.0 MPa). 
The morphological analysis of the 3D constructs produced was evaluated by scanning electron 
microscopy and by micro computed tomography. Figure 4 presents the images from the cross 
sections observed. 
Figure 4. 
The scaffolds present a very homogenous architecture with uniform pore distribution in all 
formulations, as observed by SEM. Differences in pore size and interconnectivity among 
formulations is evident by SEM images and further confirmed by micro-CT characterization 
(Table 3). The values of the different morphological parameters were determined by image 
analysis after micro-computed tomography. The interconnectivity of the scaffold is calculated 
according to the formula: , where the volume of the 
disconnected pore stands for the disconnected pore volume which was defined to be higher 
than 50 μm. The degree of isotropy is a measure of the 3D symmetry or the presence or absence 
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of preferential alignment of structures along a particular directional axis. Bone is known to be 
an anisotropic structure and this morphological characteristic of trabecular bone also plays an 
important role in the mechanical strength of the architecture produced [46]. 
 
 
In terms of porosity, the values obtained in this work are in accordance with what is reported in 
the literature (table 1), which is between 60 and 90%. In some cases, the porosity of the matrices 
produced is even slightly higher than what has been previously reported. There is one exception, 
presented by de Matos, that reports porosity values between 20 and 50%. However, the 
porosity reported was determined by mercury intrusion porosimetry and this may explain the 
low porosity reported by the authors [41]. Pore size is the parameter which can be compared 
from a larger set of data. Figure 5 presents a schematic representation of the pore size 
distribution of the matrices reported in the literature in comparison to the ones obtained in this 
work. The size of the bubbles represents the range of pore size obtained at the different 
conditions employed in each cited work. As it can be observed the pore size is much higher when 
subcritical P, T conditions are used in the foaming process (dark grey data set), possibly due to 
a distinct expansion profile of the foam.  
Figure 5. 
Most important however, is the establishment of a comparison with the data from trabecular 
bone reported in the literature [47]. The morphological analysis of the scaffolds is in very good 
agreement with this data (table 3) suggesting that the scaffolds prepared under subcritical 
carbon dioxide atmosphere can be interesting for bone regeneration applications. 
The 3D reconstruction of the structures prepared can also be obtained by micro-computed 
tomography. Figure 6 presents the reconstructed 3D architectures of the scaffolds PCL and PCL 
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+ β−TCP. This technique also allows the visualization of the distribution of β−TCP within the 
construct due to the inherently different densities of the polymer and the inorganic/ ceramic 
part. As it can be observed the foaming with β−TCP particles dispersed renders a uniform 
dispersion of the ceramic part within the structure. 
Figure 6. 
The mechanical properties of the 3D constructs produced were evaluated in compression mode. 
For an open cellular material, usually stress-strain curves are characterized by three regions, a 
linear elastic regime, a plateau and a densification region [48]. Figure 7 displays a representative 
image of the deformation that occurs upon loading and a scheme of the typical stress-strain 
deformation of a porous polymeric structure (“Example”). The elastic regime is characterized as 
a reversible region where the deformation applied can be reversed, the cell walls bend, but have 
the ability to fully recover the shape when the load or stress applied is removed. The plateau 
characteristic of the initial plastic region is a region characterized by the fracture of some cells 
and the disruption of the structure. If the force continues to be applied a densification region is 
observed, cell walls collapse and the deformation is irreversible [49]. 
A closer look at the initial mechanical properties of the two structures (Figure 7) highlights the 
fact that both PCL and PCL + β -TCP structures prepared under these operating conditions have 
a limited elastic and plateau region, and the samples present a plastic behavior typical of 
elastomeric materials. The elastic regime of both PCL and PCL + β-TCP is limited to up to 1 and 
5% strain, respectively. It is hence, in this region that the elastic modulus is determined. The 
Young modulus calculated from the initial slope of the curve (up to 1% strain) corresponds to 
2.97 ± 0.7 MPa and 1.76 ± 0.7 MPa for PCL and PCL + β−TCP, respectively. 
Figure 7. 
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De Matos and co-workers report the compressive modulus of composite PCL + mesoporous silica 
particles scaffolds prepared by supercritical fluid foaming at 35 °C and 14.0 to 25.0 MPa. In their 
work the reported scaffolds present a compressive modulus of 20-150 MPa [45]. It would 
perhaps be expected that β−TCP could enhance the mechanical properties of the scaffold, 
however, the mechanical properties are also strictly connected to the morphological features of 
the three-dimensional architectures. In our work, the mechanical properties of the scaffolds 
produced are much lower than those reported by De Matos, but the morphological features are 
also different, the porosity of the PCL + β−TCP structures herein prepared have a much higher 
porosity value (90 vs 20-50%) and the content of ceramic filler much lower (10 vs 30 wt%). 
Hence, the higher porosity, pore size and interconnectivity observed for the PCL + β−TCP may 
explain this decrease in the Young modulus. Other authors have reported the decrease in 
mechanical properties after the addition of hydroxyapatite or bioglass in PCL scaffolds [50–52]. 
The production of hybrid scaffolds loaded with inorganic fillers has not only the purpose to 
reinforce the structure but also, and most importantly to create a bioactive structure. The 
desired scaffold shall result from a fine balance between mechanical properties and bioactivity. 
Mechanical properties of bone, and particularly those in spine surgery, far exceeds the values 
herein obtained. Bone has very high mechanical properties which depend greatly on its 
hierarchical structure. While cortical bone is a compact structure, cancellous bone is composed 
of irregular, sinuous convolutions of lamellae, and these differences are highly noticeable in the 
elastic modulus of 0.1 to 0.5 GPa for cancellous bone and 12 to 18 GPa for cortical bone; and a 
compressive strength situated between 130 and 180 MPa for cortical bone [53]. Chen and co-
workers [52] report the development of porous foams as bone augments and grafts, and even 
though the mechanical properties of the polycaprolactone scaffolds produced are relatively low 
when compared to cancellous one, the in vivo study performed demonstrated a good 
performance of the scaffolds [52]. It should be highlighted that it is in fact, not only one property 
but a combination of different features that may offer distinct advantages over other materials, 
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particularly in which concerns the enhancement of bone regeneration. Polymeric scaffolds 
designed for tissue engineering and regenerative medicine applications have to meet a 
particular set of requirements, highly tailored towards compatibility and integration with 
surrounding tissue at implantation site. On what regards morphological properties, scaffolds for 
bone repair should present open and interconnected pores and adequate pore size, allowing for 
cell growth and vascularization. Scaffolds should ensure sufficient mechanical strength to 
withstand the tissue-specific biological forces and maintain cell physical integrity. Adequate 
surface properties, both chemically and topographically, should promote cell adhesion and 
proliferation. When working with biodegradable structures, its degradation rate should match 
the growth rate of the neotissue. Sterilization of the final product should be thought early in 
scaffold design, so that it will not compromise the structure properties [54–56]. It is, hence, 
extremely difficult to produce an implant that meets all the ideal criteria. Furthermore, as the 
characteristics and features of the matrices are related, sometimes the enhancement of one 
property may compromise another. For all the above, the aim is to develop scaffolds which, 
despite being far from the optimal conditions, show evidences that may lead to motivating 
outputs when implanted in vivo.    
Another important feature, related with the surface properties of the scaffolds prepared is the 
water uptake ability. The measurement of the water uptake ability provides an indication of the 
bulk hydrophilicity and thus the susceptibility of the scaffolds to suffer hydrolysis. Furthermore, 
this feature is also related with the diffusion of nutrients and oxygen to the cells together with 
the elimination of cell wastes, which occurs in an aqueous environment. Figure 8 (A) presents 
the water uptake of the PCL and PCL + β-TCP formulations tested. Both formulations present 
different water uptake abilities, where PCL + β-TCP attains nearly 70% at the first 24 h, reaching 
100% by the end of the 2-week time-frame, while PCL foams achieve nearly half water uptake 
at same time-points. After 14 days of immersion, the water uptake has reached the plateau 
region for PCL (at approx. 50%), yet not for PCL + β-TCP, which shall be able to uptake more 
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water at longer time-points. These observations can be justified by the differences observed in 
the morphological properties of the scaffolds. Larger pores and higher porosity and 
interconnectivity facilitate water diffusion into the bulk of the sample contributing to an 
enhancement of the water uptake ability of the scaffold. Additionally, the presence of β-TCP, 
has been reported to promote higher hydrophilicity of polycaprolactone scaffolds, as described 
by Zhou and co-workers [57]. One of the concerns when using synthetic polyesters is the 
possibility of degradation by hydrolysis and production of acidic residues due to the cleavage of 
the carboxylic groups [21]. For this reason, it is important to follow the pH of the solution in 
which the scaffolds are immersed. In this work, we have evaluated the changes in pH of a 
physiological solution throughout 28 days. As it can be seen in figure 8 (B), the pH of the solution 
did not change significantly upon the duration of this study. Furthermore, we have quantified 
the degree of degradation by weight loss and after 28 days, the materials present an average 
degradation of 1 wt. %, for all samples tested. These results demonstrate the high stability of 
polycaprolactone scaffolds in physiological solution. It has been recognized that 
polycaprolactone presents a long degradation time, which in vivo may vary between two and 
four years, given that its degradation occurs mostly by hydrolytic processes [7,48].  
Figure 8.  
It has long been recognized that scaffolds for tissue engineering should move from a merely 
inert structure towards a bioactive support, which is able to promote the necessary cues for an 
improved regeneration process. In addition to a ceramic material, we have evaluated the 
possibility to homogeneously disperse a second bioactive agent, namely dexamethasone. 
Dexamethasone was chosen due to the potential of this drug to direct stem cell differentiation 
towards the osteogenic lineage [58,59]. Two different drug concentrations were evaluated, and 
as demonstrated by the morphological analysis (Table 2), the presence of both β-TCP and 
dexamethasone did not compromise the porosity and interconnectivity of PCL scaffolds 
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produced under dense carbon dioxide atmosphere. In fact, a more porous and interconnected 
structure with larger pores seems to be obtained with this supplementation, which could be the 
result of distinct expansion profile of the foam. This cause-effect shall be further analyzed in 
future studies. The morphological differences of each formulation are expected to have an 
impact on mechanical performance upon application, whereas a fine balance between 
supplementation of bioactive agents and such mechanical properties shall be achieved. It was 
found that, for instance addition of β-TCP did not result in augmented young modulus upon 
compression as compared to non-supplemented PCL, possibly due to the higher porosity and 
pore size. Nevertheless, its morphology and bioactivity shall offer a more osteoinductive and 
osteoconductive environment aimed towards improved osteointegration. Pore size and porosity 
are intimately related with surface area, whereas structures with higher surface area, are more 
exposed to water molecules which shall lead to faster hydrolytic degradation of the PCL 
component. These can be fine-tuned in order to reach the best performing structure on what 
regards matching new bone formation and scaffold degradation rates, as well as controlled 
release of bioactive agents such as the dexamethasone. The in vitro drug release profile was 
followed up to 35 days in an isotonic physiological solution and the results are presented in 
figure 9. 
Figure 9. 
Dexamethasone was sustainably released from the scaffolds within one month. Up to 24 hours 
there are no relevant differences between the two systems, loaded with 5 or 10 wt% of 
dexamethasone. The release profile presented a lag time of 2 hours before dexamethasone 
could be detected in the release media. Between 2 and 6 hours there is an eventual burst release 
as the drug concentration in solution increased. From this point onwards, there is a controlled 
release of the drug from the scaffold. The release profile of both structures presents a parallel 
trend, suggesting that the mechanisms underlying the release are the same and the differences 
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encountered are only due to the differences in the loaded concentrations. At the end of this 
study, and as it would be expected, the cumulative amount of dexamethasone in solution is 
higher for the samples prepared with 10 wt% dex, however, these samples have a slower release 
rate than the scaffolds impregnated with 5 wt% dex. After 35 days, the scaffolds loaded with 5 
wt% have released 100% of the drug impregnated while the scaffolds loaded with 10 wt% have 
released approximately 75% of the drug.  
One of the most important requirements in a scaffold for tissue engineering and regenerative 
medicine is the biocompatibility of the material. Hence, the cytotoxicity of the materials 
prepared was evaluated by an indirect contact in which the cells are cultured in the presence of 
the materials leachables extracted for 24 hours. Cell viability determined by MTS assay was 
determined as a function of the cell viability of the cells cultured with DMEM culture media. The 
results for the different formulations are presented in figure 10. 
Figure 10.  
The results demonstrate that the leachables of the different structures prepared do not 
compromise the viability and metabolic activity of the cells and hence could be used as scaffolds 
for tissue engineering applications. 
 
4. Conclusions 
In this work, we evaluated the possibility to prepare 3D scaffolds from polycaprolactone under 
dense subcritical carbon dioxide atmosphere. Processing technologies, carried out to pressures 
up to 5.0 MPa can encourage the development of new materials, the use of cheaper equipment, 
eliminating the need for cooling systems, liquid pumps, compressors and all the negative 
connotation of the “high-pressure” concept without the need to go up to supercritical 
conditions. Unlike the studies reported in the literature, it was possible to create porous 
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structures without the need to use supercritical condition, i.e pressures below 74 MPa. The 
structures prepared present interesting morphological and mechanical properties to be used as 
scaffolds in bone tissue engineering and regenerative medicine and open new perspectives for 
the treatment of bone defects by in situ foaming, through the development of a portable surgical 
tool. Furthermore, osteoconductive and osteoinductive active agents were incorporated into 
PCL in a single operating step: β-tricalcium phosphate and dexamethasone were 
homogeneously dispersed within the PCL matrix. Dexamethasone was released sustainably from 
the constructs, with a higher delivery rate during the first week of the study, enhancing the 
functionality of the PCL scaffold. The cytotoxicity of the materials produced was also studied 
and the different formulations tested did not show any compromise of the cell viability after 48 
hours of contact. Overall, the results obtained prove that this novel hybrid structure might be a 
promising approach as a multifunctional template for regenerative medicine applications.  
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Figure Captions 
Figure 1. Schematic representation of the supercritical foaming equipment. BPR: Back Pressure 
Regulator, P: Pressure Transducer, TIC: Temperature Controller, FM: Flow Meter, CO2: Carbon 
Dioxide.  
Figure 2. Schematic representation of processing conditions (pressure and temperature) used 
in the work reported in the literature (circle symbol) as well as the conditions proposed herein 
(cross symbol). 
Figure 3. Effect of time on the plasticization and foaming of polycaprolactone under dense 
carbon dioxide atmosphere at 45 °C. 
Figure 4. Scanning electron microscopy (top row, scale bar: 500 μm) and micro-computed 
tomography images (bottom row) of the different formulations processed at 45 °C and 5.0 MPa. 
Figure 5. Comparison of pore size of the PCL foams prepared in the literature (Table 1) and those 
described in this work (light grey – supercritical foaming conditions; dark grey – subcritical 
foaming conditions). Circle diameter represent the range of pore size reported in each work. 
Figure 6. Micro-computed tomography 3D reconstruction images of the scaffolds produced at 
45 °C, 5.0 MPa. 
Figure 7: Strain-stress curves obtained in compression mode for the 3D constructs PCL and PCL 
+ β-TCP, compared with a typical stress-strain curve as Example. Bottom left: A close-up of the 
elastic regime area. 
Figure 8. Water uptake of the scaffolds (A) and pH of the solution (B) as a function of time for 
the scaffolds PCL (closed symbols) and PCL + β-TCP (open symbols) 
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Figure 9. In vitro release profile of the samples loaded with 5 wt% dex (open symbols) and 10 
wt% dex (closed symbols), represented as Cumulative drug released (mg) (A) or Percentage of 
drug released (%). Bottom left: A close-up of the early time-points. 
Figure 10. Cytotoxicity assay: cell viability (%) determined by indirect contact. 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 1 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 2 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 3 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 4 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 5 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 6 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 7 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 8 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 9 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Fig 10 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
Table 1. Summary of the supercritical fluid studies on foaming of polycaprolactone reported in 
the literature. 
 Operating parameters Morphological 
properties 
Mechanical 
properties 
Additives Pressu
re 
range 
Temperat
ure range 
Molecu
lar 
weight 
Porosi
ty 
Pore size Compress
ive 
modulus 
Referen
ce 
 (MPa) (°C) (Da) (%) m) (MPa)  
Talc 6.2 70 - Data 
not 
shown 
Data not 
shown 
Data not 
shown 
[25] 
 6.9* 24-30** 80 000 Data 
not 
shown 
100 Pin > 
Pc CO2 
450 - 700 
Pin < Pc 
CO2 
Data not 
shown 
[26] 
 8.0-
16.0 
40 85 000 Data 
not 
shown 
40 -160 Data not 
shown 
[27] 
Ethanol 12.3-
20.5 
35-45 80 000 Data 
not 
shown 
40 - 80 Data not 
shown 
[28] 
 21.0-
45.0 
20-50 14 000 Data 
not 
shown 
Data not 
shown 
Data not 
shown 
[29] 
Ethyl 
lactacte 
20.0 40-45 80 000 65-
80% 
50 -200  Data not 
shown 
[30–32] 
5-
fluorouracil, 
nicotinamid
e and 
triflusal 
20.0 40 80 000 
61-
74% 
87-337 
Data not 
shown 
[33] 
NaCl 8.0 50 30 -50 
000 
Data 
not 
shown 
427 Data not 
shown 
[34] 
HA 20.0 37 65 000 ~90% 50-70 and 
100-300 
Data not 
shown 
[35] 
 20.0-
30.0 
40-60 80 000 Data 
not 
shown 
80-200 Data not 
shown 
[36] 
Elastin + 
NaCl 
6.5 70 80 000 70-90 
% 
200-500 Data not 
shown 
[37] 
 7.8-
20.0 
25-50 69-120 
000 
65-90 
% 
170-350  Data not 
shown 
[38] 
 10.0-
20.0 
30-45 74 000 Data 
not 
shown 
110-360 Data not 
shown 
[39] 
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 2.8-5.9 29-45** 80 000 Data 
not 
shown 
80-300 Data not 
shown 
[40] 
Mesoporous 
silica 
particles 
Dexamethas
one + 
14.0-
25.0 
35 40 000 
20-
50% 
no 
macroporo
sity 
evaluated 
20-250 [41] 
 8.2 60 70 000 Data 
not 
shown 
Data not 
shown 
Data not 
shown 
[42] 
*Psat bewteen 6.9 and 32 MPa **T sat = 70ºC 
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 Table 2: Summary of the different formulations prepared in this work (PCL (Mn 45000 Da) 
mass was kept constant in all formulations, 500 mg were used). 
# Designation 
β-TCP 
(wt %) 
Dexamethasone 
(wt %) 
1 PCL - - 
2 PCL + β-TCP 10 - 
3 PCL + β-TCP + dex5 10 5 
4 PCL + β-TCP + dex10 10 10 
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 Table 3. Morphological characterization of the scaffolds by microCT. 
 
PCL 
PCL + 
β−TCP 
PCL + β−TCP +  
5 dex 
PCL + β−TCP 
+ 10 dex 
Trabecular 
bone [47] 
Porosity (%)  73 90 98 84 52-96 
Pore Interconnectivity (%)  79 97 99 95 - 
Mean pore size (μm)  164 383 882 664 450-1310 
Density (mm-1)  28 54 66 31 7-34 
Degree of anisotropy  1.42 1.48 1.38 1.48 1.1-2.38 
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